BioTalk is a news hub brought to you by Bird & Bird's International Life Sciences & Healthcare Group. Read more about us >

Healthcare

Sort by Latest
First medicinal cannabis drug listed on the Australian Pharmaceuticals Benefits Scheme
On 1 May 2021 Epidyolex, the first medicinal cannabis drug product was listed on the Pharmaceutical Benefits Scheme (PBS). The costs of drug products listed on the PBS are subsidised by the Australian Government. Epidyolex is used in combination with at least two other anti-epileptic medicines to treat Dravet syndrome – a genetic epileptic disease that gives rise to seizures that doesn’t respond well to standard medications. While Epidyolex is the second medicinal cannabis drug registered for...
May 6, 2021
1 min read
EU merger control – new guidance brings uncertainty...
Illumina’s acquisition of cancer testing startup, Grail, looks...
April 20, 2021
7 min read
Singapore Gets Vaccinated! Introduction of the Pandemic...
As part of a slew of measures to mitigate the effect...
March 25, 2021
6 min read
Introduction of the Narcotic Drugs Amendment (Medicinal...
On the 3rd February 2021, the Narcotic Drugs Amendment (Medicinal...
March 2, 2021
1 min read
Impact of Brexit on Artificial Intelligence in Healthcare
AI developments in the UK The UK is starting to uncover significant opportunities...
February 5, 2021
5 min read
Indirect infringement in Spanish courts: a trend reversal and some teachings concerning infringement of second use medical claims
The specialised Section No. 15 of the Appeal Court of Barcelona has recently clarified what indirect...
January 22, 2021
4 min read
Chinese patent linkage system – the Chinese Supreme Court issues Draft Judicial Interpretations
The Chinese Supreme Court (“SPC”) released on 29 October 2020 the “Provisions on Several...
November 13, 2020
6 min read
Managing Scientific Collaboration Agreements within the French Healthtech Sector
Scientific Collaboration Agreements allow a public servant, most of the time a researcher, (who...
November 9, 2020
5 min read
Australian Courts apply “European Support” test to find key Wyeth’s Prevnar 13 patent invalid
In the recent decision in the Australian front of the Prevnar 13 patent litigation, Merck...
November 4, 2020
10 min read
AstraZeneca held liable for additional healthcare costs
In a judgment of 14 October 2020 the District Court The Hague ruled in a landslide decision that AstraZeneca...
October 15, 2020
10 min read
Cookie consent
We use analytics cookies to help us understand if our website is working well and to learn what content is most useful to visitors. We also use some cookies which are essential to make our website work. You can accept or reject our analytic cookies (including the collection of associated data) and change your mind at any time. Find out more in our Cookie Notice.